Public dataset
Recorded source agreement and disagreement
Show whether sources print one normalized reading, have incompatible units, lack structured comparison context, or contain a context-matched numeric difference.
What this does not mean: agree can mean only that sources print the same normalized reading; it is not clinical-context equivalence, independent replication, or proof. differ requires matching structured context and disjoint comparable values. not_comparable and insufficient_context are not disagreement.
- Public rows
- 1,681
- Generated
- Schema version
- source-consensus/2
Coverage
What this run contains
- Compared medicine fields
- 1,681
- Agree
- 1,282
- Differ
- 0
- Not comparable
- 12
- Insufficient context
- 387
- Fields represented
- 5
- bioavailability, halfLife, proteinBinding, tMax, volumeOfDistribution
Method
How the rows were made
- Deterministic rules normalize recorded pharmacokinetic readings and compare only like-for-like values.
- One normalized printed reading may be agree even when clinical context was not extracted; this reports printed-reading agreement only.
- Distinct readings may differ only when their units and denominators are comparable and one matching, non-placeholder population/formulation context was structurally extracted. Otherwise they are insufficient_context.
- not_comparable preserves incompatible units or denominators instead of guessing. insufficient_context preserves missing or non-matching structured context instead of manufacturing agreement or disagreement.
- The agreement rate describes the distribution of recorded source readings; it is not a probability that a value is true.
- Every distinct printed reading retains its unit, population context, source count, and complete source records. The API paginates field rows, never child readings or sources.
- documentsExamined is every matching single-substance archive document inspected for that medicine. The generator has no document, reading, or source ceiling, so there is no hidden available-versus-retained remainder.
Limits
Read these before using a row
- Current label parsing does not structurally extract population or formulation context. Distinct otherwise-comparable readings are therefore insufficient_context, never differ; agree may mean printed-reading agreement only. Source records are complete but are not independent-experiment counts.
- The current deterministic parser does not structurally extract population or formulation context from these sentences. It records that context as unknown and cannot publish distinct same-unit readings as differ.
- Neither reading is marked wrong. Population, formulation, route, and other unextracted context may explain the printed difference.
- Only the recorded fields and source documents in this snapshot are compared.
- A source count is the number of retained source records in the row, not a count of independent experiments.
Provenance
Source examples
abacavir · bioavailability · agree
15 documents examined; 83% (Unknown: population and formulation context were not structurally extracted from this source sentence.)
FDA_LABEL:5676d391-f9a4-44be-9604-954b3d8d0e2b (opens source in a new tab)The geometric mean absolute bioavailability of the tablet was 83%.
alemtuzumab · volumeOfDistribution · not_comparable
2 documents examined; 0.18 L/kg (Unknown: population and formulation context were not structurally extracted from this source sentence.); 14.1 L (Unknown: population and formulation context were not structurally extracted from this source sentence.)
FDA_LABEL:4f5f7255-7abc-4328-bd1a-ceaf139ef3e0 (opens source in a new tab)Distribution After the last 30 mg dose, the mean volume of distribution at steady-state was 0.18 L/kg (range 0.1 to 0.4 L/kg).
abiraterone · halfLife · insufficient_context
31 documents examined; 12 ± 5 hours (Unknown: population and formulation context were not structurally extracted from this source sentence.); 18 hours (Unknown: population and formulation context were not structurally extracted from this source sentence.)
FDA_LABEL:c9eb9b46-f847-40a8-802c-a51b40406d5a (opens source in a new tab)Elimination In patients with metastatic CRPC, the mean terminal half-life of abiraterone in plasma (mean ± SD) is 12 ± 5 hours.
Artifact used for this view: data/source-consensus.ndjson. The reader resolves the current run first and uses the checked-in compatibility run only when a current artifact is absent.
Schema
Fields in the public projection
| Field | Type | Meaning |
|---|---|---|
| medicineSlug | string | Stable RNAWiki medicine route key. |
| field | string | Recorded pharmacokinetic field being compared. |
| comparisonState | string | agree (printed-reading agreement), differ (context-matched comparable disjoint values), not_comparable (unit/denominator mismatch), or insufficient_context. Every state remains declared even when its current count is zero. |
| comparisonReasons | string[] | Deterministic codes explaining the state. |
| documentsExamined | number | Recorded source documents considered for the field. |
| sourceCount | number | Recorded source readings represented. |
| agreementRate | number | Share represented by the leading normalized printed-reading group; not a confidence score or clinical agreement probability. |
| readings | consensus-reading[] | Complete, untruncated reading groups. Each keeps the printed display, numeric value when parsed, unit, population context, source count, and every source identity, version/effective date or explicit absence, retrieval date, locator, safe link, and excerpt. |
Reader
Search and filter the rows
Showing 951–960 of 1,681 matching rows. Filters and search terms remain attached when you move between pages or open the API view.
Projected row 951
- Medicine slug
- metaxalone
- Compared field
- tMax
- Comparison state
- insufficient_context
- Reason codes
- STRUCTURED_CONTEXT_MISSING
- Documents examined
- 58
- Source count
- 57
- Agreement rate
- 0.526316
- Recorded readings
3.3 hours
- Numeric value
- 3.3
- Unit
- hours
- Source records
- 30
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 30 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c91c0fb0-0b61-4e45-8bea-d0bf57ca7068 (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Peak plasma metaxalone concentrations occurred at a mean T max of 3.3 hours (1.5 hours to 5 hours) of metaxalone under fasted conditions.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f2b46d69-1c20-5ae9-e053-2a95a90a60a9 (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Peak plasma metaxalone concentrations occurred at a mean T max of 3.3 hours (1.5 hours to 5 hours) of metaxalone under fasted conditions.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4c3ae824-48a9-fd91-e063-6394a90a9a54 (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Peak plasma metaxalone concentrations occurred at a mean T max of 3.3 hours (1.5 to 5 hours) of metaxalone under fasted conditions.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f4a0e910-2b20-46d4-b49e-21fb15925b58 (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Peak plasma metaxalone concentrations occurred at a mean T max of 3.3 hours (1.5 – 5 hours) of metaxalone tablets under fasted conditions.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e9e45029-b1a4-435f-b9ca-cdfa01051bc8 (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Peak plasma metaxalone concentrations occurred at a mean T max of 3.3 hours (1.5 – 5 hours) of metaxalone under fasted conditions.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:45726fbc-3450-63f7-e063-6394a90a671a (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Peak plasma metaxalone concentrations occurred at a mean Tmax of 3.3 hours (1.5 – 5 hours) of metaxalone tablets under fasted conditions.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a12304b7-6477-4518-8db5-898879c62caf (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Peak plasma metaxalone concentrations occurred at a mean T max of 3.3 hours (1.5 – 5 hours) of metaxalone under fasted conditions.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3a7c8b4d-7add-cb31-e063-6294a90a37f8 (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Peak plasma metaxalone concentrations occurred at a mean T max of 3.3 hours (1.5 – 5 hours) of metaxalone tablets under fasted conditions.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4c3b2aa4-fe65-507c-e063-6394a90a7b00 (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Peak plasma metaxalone concentrations occurred at a mean T max of 3.3 hours (1.5 to 5 hours) of metaxalone under fasted conditions.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fe82b33b-2a24-4477-91ca-b23e59156675 (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Peak plasma metaxalone concentrations occurred at a mean T max of 3.3 hours (1.5 hours to 5 hours) of metaxalone under fasted conditions.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a662fd07-2896-4cbb-bafc-aa5ab179a148 (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Peak plasma metaxalone concentrations occurred at a mean T max of 3.3 hours (1.5 – 5 hours) of metaxalone under fasted conditions.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8c1e10fe-0330-4bf8-a94d-aeed80f6aef1 (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Peak plasma metaxalone concentrations occurred at a mean T max of 3.3 hours (1.5 hours to 5 hours) of metaxalone under fasted conditions.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1cef46bb-e590-4a58-82e0-7cf1fc3836a5 (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Peak plasma metaxalone concentrations occurred at a mean T max of 3.3 hours (1.5 hours to 5 hours) of metaxalone under fasted conditions.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b3a4f6bc-abd4-4b8e-970f-59b3aa6f17a0 (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Peak plasma metaxalone concentrations occurred at a mean T max of 3.3 hours (1.5 – 5 hours) of metaxalone tablets under fasted conditions.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3e7efad7-2752-4f7d-ba30-40f17d13e4c3 (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Peak plasma metaxalone concentrations occurred at a mean T max of 3.3 hours (1.5 – 5 hours) of metaxalone under fasted conditions.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1541da6a-7681-40bc-b67e-28e02a950d72 (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Peak plasma metaxalone concentrations occurred at a mean T max of 3.3 hours (1.5 – 5 hours) of metaxalone under fasted conditions.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5de36266-3964-5aca-e053-2991aa0a2205 (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Peak plasma metaxalone concentrations occurred at a mean T max of 3.3 hours (1.5 – 5 hours) of metaxalone tablets under fasted conditions.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3aa9dba9-29b0-4520-a0f7-66d19d52c6bc (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Peak plasma metaxalone concentrations occurred at a mean T max of 3.3 hours (1.5 to 5 hours) of metaxalone under fasted conditions.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:413b300d-4163-afef-e063-6394a90a618f (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Peak plasma metaxalone concentrations occurred at a mean T max of 3.3 hours (1.5 – 5 hours) of metaxalone under fasted conditions.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5bcdc9d3-8827-4d05-8783-4519f1b284a3 (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Peak plasma metaxalone concentrations occurred at a mean T max of 3.3 hours (1.5 – 5 hours) of metaxalone tablets under fasted conditions.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d4caa7c6-afb5-43a2-ba38-cf30106b1d62 (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Peak plasma metaxalone concentrations occurred at a mean T max of 3.3 hours (1.5 – 5 hours) of metaxalone under fasted conditions.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:de3448df-4ca1-44ec-bad1-486549cddf64 (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Peak plasma metaxalone concentrations occurred at a mean T max of 3.3 hours (1.5 – 5 hours) of metaxalone under fasted conditions.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c86862a4-f6ff-4268-bec6-35dedbe4cd4a (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Peak plasma metaxalone concentrations occurred at a mean T max of 3.3 hours (1.5 – 5 hours) of metaxalone under fasted conditions.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4facde6f-1828-9138-e063-6294a90a1ec1 (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Peak plasma metaxalone concentrations occurred at a mean T max of 3.3 hours (1.5 hours to 5 hours) of metaxalone under fasted conditions.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:02eb5938-cd59-4a81-853d-a4148d813a94 (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Peak plasma metaxalone concentrations occurred at a mean T max of 3.3 hours (1.5 hours to 5 hours) of metaxalone under fasted conditions.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d9cefc55-7643-ce9b-e053-2a95a90aff12 (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Peak plasma metaxalone concentrations occurred at a mean T max of 3.3 hours (1.5 – 5 hours) of metaxalone under fasted conditions.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:edc6ba8d-2d45-4833-8dc7-e2d4e5d72856 (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Peak plasma metaxalone concentrations occurred at a mean T max of 3.3 hours (1.5 hours to 5 hours) of metaxalone under fasted conditions.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:36c1d263-48ce-831b-e063-6394a90a0a2b (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Peak plasma metaxalone concentrations occurred at a mean T max of 3.3 hours (1.5 hours to 5 hours) of metaxalone under fasted conditions.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8294bb3c-c8eb-474c-b567-e53cf81249e9 (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Peak plasma metaxalone concentrations occurred at a mean T max of 3.3 hours (1.5 – 5 hours) of metaxalone under fasted conditions.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a23ca660-b066-1396-e053-2a95a90a30b2 (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Peak plasma metaxalone concentrations occurred at a mean T max of 3.3 hours (1.5 – 5 hours) of metaxalone under fasted conditions.
3 hours
- Numeric value
- 3
- Unit
- hours
- Source records
- 26
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 26 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bd1c9022-aadc-af1f-e053-2995a90a0b42 (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Absorption Peak plasma concentrations of metaxalone occur approximately 3 hours after a 400 mg oral dose under fasted conditions.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c796d4a1-fad4-4a0c-a459-8ae3b5b52fb6 (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Absorption Peak plasma concentrations of metaxalone occur approximately 3 hours after a 400 mg oral dose under fasted conditions.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7f758053-2367-4c5f-9bbd-ce8ce263a615 (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Absorption Peak plasma concentrations of metaxalone occur approximately 3 hours after a 400 mg oral dose under fasted conditions.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b3279496-293e-7e1f-e053-2a95a90ab506 (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Absorption Peak plasma concentrations of metaxalone occur approximately 3 hours after a 400 mg oral dose under fasted conditions.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9b21a974-6a5a-9efb-e9de-470363217126 (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Absorption Peak plasma concentrations of metaxalone occur approximately 3 hours after a 400 mg oral dose under fasted conditions.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c1f49112-e8ce-43a9-bdb8-1a3db4fb6bc4 (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Absorption Peak plasma concentrations of metaxalone occur approximately 3 hours after a 400 mg oral dose under fasted conditions.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f06f2b96-3684-483c-89f7-6c9201fd4664 (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Absorption Peak plasma concentrations of metaxalone occur approximately 3 hours after a 400 mg oral dose under fasted conditions.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8c3bc0a2-5c93-e1d6-e053-2995a90a0b83 (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Absorption Peak plasma concentrations of metaxalone occur approximately 3 hours after a 400 mg oral dose under fasted conditions.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:01199953-8124-4ace-947f-7b11989b44c3 (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Absorption Peak plasma concentrations of metaxalone occur approximately 3 hours after a 400 mg oral dose under fasted conditions.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ee86f52c-fbf4-4882-bb7d-50220736fbb3 (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Absorption Peak plasma concentrations of metaxalone occur approximately 3 hours after a 400 mg oral dose under fasted conditions.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9b7b4fc3-3f38-db66-e053-2995a90aaadb (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Absorption Peak plasma concentrations of metaxalone occur approximately 3 hours after a 400 mg oral dose under fasted conditions.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:91432cd0-8404-8029-e053-2a95a90adc1b (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Absorption Peak plasma concentrations of metaxalone occur approximately 3 hours after a 400 mg oral dose under fasted conditions.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4a558a2f-f9be-40d1-8d02-dd0c8c501ef6 (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Absorption Peak plasma concentrations of metaxalone occur approximately 3 hours after a 400 mg oral dose under fasted conditions.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d0276e7b-a1c9-61f3-e053-2a95a90ae3aa (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Absorption Peak plasma concentrations of metaxalone occur approximately 3 hours after a 400 mg oral dose under fasted conditions.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f05bb280-6736-4215-be5b-0e5f7991cd87 (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Absorption Peak plasma concentrations of metaxalone occur approximately 3 hours after a 400 mg oral dose under fasted conditions.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:87518046-c959-d5f3-e053-2a95a90a5f7e (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Absorption Peak plasma concentrations of metaxalone occur approximately 3 hours after a 400 mg oral dose under fasted conditions.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9c7d0cd4-625a-485e-9d13-ce854630148c (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Absorption Peak plasma concentrations of metaxalone occur approximately 3 hours after a 400 mg oral dose under fasted conditions.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fba1601d-3ac4-41cf-9548-35ec4994a95e (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Absorption Peak plasma concentrations of metaxalone occur approximately 3 hours after a 400 mg oral dose under fasted conditions.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ef47682d-ea41-465e-aa21-cc773d45a6f0 (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Absorption Peak plasma concentrations of metaxalone occur approximately 3 hours after a 400 mg oral dose under fasted conditions.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c2dd7071-cba3-410c-ade5-9d7e5af42038 (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Absorption Peak plasma concentrations of metaxalone occur approximately 3 hours after a 400 mg oral dose under fasted conditions.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:07ccff59-e335-40be-9e40-fd2d08197617 (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Absorption Peak plasma concentrations of metaxalone occur approximately 3 hours after a 400 mg oral dose under fasted conditions.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:49250bbf-fbfe-07cd-e054-00144ff88e88 (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Absorption Peak plasma concentrations of metaxalone occur approximately 3 hours after a 400 mg oral dose under fasted conditions.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:02c42f72-5d78-436d-8105-8c0f8d4c0d91 (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Absorption Peak plasma concentrations of metaxalone occur approximately 3 hours after a 400 mg oral dose under fasted conditions.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b6afb4d3-eb3e-4e9f-9aa9-a44cfacb959c (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Absorption Peak plasma concentrations of metaxalone occur approximately 3 hours after a 400 mg oral dose under fasted conditions.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b713a0f2-d47a-0ae7-e053-2995a90a5b85 (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Absorption Peak plasma concentrations of metaxalone occur approximately 3 hours after a 400 mg oral dose under fasted conditions.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8aa84e64-0075-4f22-a576-da085f32d56c (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Absorption Peak plasma concentrations of metaxalone occur approximately 3 hours after a 400 mg oral dose under fasted conditions.
3.5 hours
- Numeric value
- 3.5
- Unit
- hours
- Source records
- 1
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 1 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fc6de1a6-26aa-47ac-a5d2-bf127a6ca563 (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
The time-to-peak plasma concentration (T max ) occurred at 3.5 hours (range 1.5-12 hours).
Projected row 952
- Medicine slug
- metaxalone
- Compared field
- volumeOfDistribution
- Comparison state
- insufficient_context
- Reason codes
- STRUCTURED_CONTEXT_MISSING
- Documents examined
- 58
- Source count
- 57
- Agreement rate
- 0.54386
- Recorded readings
800 Liters
- Numeric value
- 800
- Unit
- L
- Source records
- 31
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 31 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c91c0fb0-0b61-4e45-8bea-d0bf57ca7068 (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Distribution Metaxalone apparent volume of distribution is approximately 800 Liters; however, plasma protein binding is unknown.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f2b46d69-1c20-5ae9-e053-2a95a90a60a9 (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
L) T max (hrs) t 1/2 (hrs) 400 mg 0.5 times the approved recommended dose. ↑ 78% ↑ 24% ↑ 15% ↑ 30% ↓ 73% 800 mg ↑ 94% ↑ 46% ↑ 42% ↑ 63% ↓ 48% Distribution Metaxalone apparent volume of distribution is approximately 800 Liters; however, plasma protein binding is unknown.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4c3ae824-48a9-fd91-e063-6394a90a9a54 (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Distribution Metaxalone apparent volume of distribution is approximately 800 Liters; however, plasma protein binding is unknown.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f4a0e910-2b20-46d4-b49e-21fb15925b58 (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Distribution Metaxalone apparent volume of distribution is approximately 800 Liters; however, plasma protein binding is unknown.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e9e45029-b1a4-435f-b9ca-cdfa01051bc8 (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Distribution Metaxalone apparent volume of distribution is approximately 800 Liters; however, plasma protein binding is unknown.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:45726fbc-3450-63f7-e063-6394a90a671a (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Distribution Metaxalone apparent volume of distribution is approximately 800 Liters; however, plasma protein binding is unknown.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a12304b7-6477-4518-8db5-898879c62caf (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Distribution Metaxalone apparent volume of distribution is approximately 800 Liters; however, plasma protein binding is unknown.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3a7c8b4d-7add-cb31-e063-6294a90a37f8 (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Distribution Metaxalone apparent volume of distribution is approximately 800 Liters; however, plasma protein binding is unknown.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fc6de1a6-26aa-47ac-a5d2-bf127a6ca563 (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Distribution For Metaxalone Tablets, 640 mg, the metaxalone apparent volume of distribution (V/F) was approximately 800 Liters.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4c3b2aa4-fe65-507c-e063-6394a90a7b00 (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Distribution Metaxalone apparent volume of distribution is approximately 800 Liters; however, plasma protein binding is unknown.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fe82b33b-2a24-4477-91ca-b23e59156675 (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
L) T max (hrs) t 1/2 (hrs) 400 mg 0.5 times the approved recommended dose. ↑ 78% ↑ 24% ↑ 15% ↑ 30% ↓ 73% 800 mg ↑ 94% ↑ 46% ↑ 42% ↑ 63% ↓ 48% Distribution Metaxalone apparent volume of distribution is approximately 800 Liters; however, plasma protein binding is unknown.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a662fd07-2896-4cbb-bafc-aa5ab179a148 (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Distribution Metaxalone apparent volume of distribution is approximately 800 Liters; however, plasma protein binding is unknown.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8c1e10fe-0330-4bf8-a94d-aeed80f6aef1 (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
L) T max (hrs) t 1/2 (hrs) 400 mg 0.5 times the approved recommended dose. ↑ 78% ↑ 24% ↑ 15% ↑ 30% ↓ 73% 800 mg ↑ 94% ↑ 46% ↑ 42% ↑ 63% ↓ 48% Distribution Metaxalone apparent volume of distribution is approximately 800 Liters; however, plasma protein binding is unknown.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1cef46bb-e590-4a58-82e0-7cf1fc3836a5 (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
L) T max (hrs) t 1/2 (hrs) 400 mg 0.5 times the approved recommended dose. ↑ 78% ↑ 24% ↑ 15% ↑ 30% ↓ 73% 800 mg ↑ 94% ↑ 46% ↑ 42% ↑ 63% ↓ 48% Distribution Metaxalone apparent volume of distribution is approximately 800 Liters; however, plasma protein binding is unknown.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b3a4f6bc-abd4-4b8e-970f-59b3aa6f17a0 (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Distribution Metaxalone apparent volume of distribution is approximately 800 Liters; however, plasma protein binding is unknown.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3e7efad7-2752-4f7d-ba30-40f17d13e4c3 (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Distribution Metaxalone apparent volume of distribution is approximately 800 Liters; however, plasma protein binding is unknown.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1541da6a-7681-40bc-b67e-28e02a950d72 (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Distribution Metaxalone apparent volume of distribution is approximately 800 Liters; however, plasma protein binding is unknown.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5de36266-3964-5aca-e053-2991aa0a2205 (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Distribution Metaxalone apparent volume of distribution is approximately 800 Liters; however, plasma protein binding is unknown.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3aa9dba9-29b0-4520-a0f7-66d19d52c6bc (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Distribution Metaxalone apparent volume of distribution is approximately 800 Liters; however, plasma protein binding is unknown.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:413b300d-4163-afef-e063-6394a90a618f (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Distribution Metaxalone apparent volume of distribution is approximately 800 Liters; however, plasma protein binding is unknown.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5bcdc9d3-8827-4d05-8783-4519f1b284a3 (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Distribution Metaxalone apparent volume of distribution is approximately 800 Liters; however, plasma protein binding is unknown.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d4caa7c6-afb5-43a2-ba38-cf30106b1d62 (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Distribution Metaxalone apparent volume of distribution is approximately 800 Liters; however, plasma protein binding is unknown.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:de3448df-4ca1-44ec-bad1-486549cddf64 (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Distribution Metaxalone apparent volume of distribution is approximately 800 Liters; however, plasma protein binding is unknown.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c86862a4-f6ff-4268-bec6-35dedbe4cd4a (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Distribution Metaxalone apparent volume of distribution is approximately 800 Liters; however, plasma protein binding is unknown.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4facde6f-1828-9138-e063-6294a90a1ec1 (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
L) T max (hrs) t 1/2 (hrs) 400 mg 0.5 times the approved recommended dose. ↑ 78% ↑ 24% ↑ 15% ↑ 30% ↓ 73% 800 mg ↑ 94% ↑ 46% ↑ 42% ↑ 63% ↓ 48% Distribution Metaxalone apparent volume of distribution is approximately 800 Liters; however, plasma protein binding is unknown.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:02eb5938-cd59-4a81-853d-a4148d813a94 (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
L) T max (hrs) t 1/2 (hrs) 400 mg 0.5 times the approved recommended dose. ↑ 78% ↑ 24% ↑ 15% ↑ 30% ↓ 73% 800 mg ↑ 94% ↑ 46% ↑ 42% ↑ 63% ↓ 48% Distribution Metaxalone apparent volume of distribution is approximately 800 Liters; however, plasma protein binding is unknown.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d9cefc55-7643-ce9b-e053-2a95a90aff12 (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Distribution Metaxalone apparent volume of distribution is approximately 800 Liters; however, plasma protein binding is unknown.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:edc6ba8d-2d45-4833-8dc7-e2d4e5d72856 (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
L) T max (hrs) t 1/2 (hrs) 400 mg 0.5 times the approved recommended dose. ↑ 78% ↑ 24% ↑ 15% ↑ 30% ↓ 73% 800 mg ↑ 94% ↑ 46% ↑ 42% ↑ 63% ↓ 48% Distribution Metaxalone apparent volume of distribution is approximately 800 Liters; however, plasma protein binding is unknown.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:36c1d263-48ce-831b-e063-6394a90a0a2b (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
L) T max (hrs) t 1/2 (hrs) 400 mg 0.5 times the approved recommended dose. ↑ 78% ↑ 24% ↑ 15% ↑ 30% ↓ 73% 800 mg ↑ 94% ↑ 46% ↑ 42% ↑ 63% ↓ 48% Distribution Metaxalone apparent volume of distribution is approximately 800 Liters; however, plasma protein binding is unknown.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8294bb3c-c8eb-474c-b567-e53cf81249e9 (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Distribution Metaxalone apparent volume of distribution is approximately 800 Liters; however, plasma protein binding is unknown.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a23ca660-b066-1396-e053-2a95a90a30b2 (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Distribution Metaxalone apparent volume of distribution is approximately 800 Liters; however, plasma protein binding is unknown.
800 L
- Numeric value
- 800
- Unit
- L
- Source records
- 26
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 26 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bd1c9022-aadc-af1f-e053-2995a90a0b42 (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Distribution, Metabolism, and Excretion Although plasma protein binding and absolute bioavailability of metaxalone are not known, the apparent volume of distribution (V/F ~ 800 L) and lipophilicity (log P = 2.42) of metaxalone suggest that the drug is extensively distributed in the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c796d4a1-fad4-4a0c-a459-8ae3b5b52fb6 (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Mean (SD) Concentrations of Metaxalone following an 800 mg Dose under fasted and Fed Conditions Distribution, Metabolism, and Excretion Although plasma protein binding and absolute bioavailability of metaxalone are not known, the apparent volume of distribution (V/F ~ 800 L) and lipophilicity (log P = 2.42) of metaxalone suggest that the drug is extensively distributed in the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7f758053-2367-4c5f-9bbd-ce8ce263a615 (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Distribution, Metabolism, and Excretion Although plasma protein binding and absolute bioavailability of metaxalone are not known, the apparent volume of distribution (V/F ~ 800 L) and lipophilicity (log P = 2.42) of metaxalone suggest that the drug is extensively distributed in the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b3279496-293e-7e1f-e053-2a95a90ab506 (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Distribution, Metabolism, and Excretion Although plasma protein binding and absolute bioavailability of metaxalone are not known, the apparent volume of distribution (V/F ~ 800 L) and lipophilicity (log P = 2.42) of metaxalone suggest that the drug is extensively distributed in the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9b21a974-6a5a-9efb-e9de-470363217126 (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
f a high fat meal (Figure 1). figure 1 Distribution, Metabolism, and Excretion Although plasma protein binding and absolute bioavailability of metaxalone are not known, the apparent volume of distribution (V/F ~ 800 L) and lipophilicity (log P = 2.42) of metaxalone suggest that the drug is extensively distributed in the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c1f49112-e8ce-43a9-bdb8-1a3db4fb6bc4 (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Distribution, Metabolism, and Excretion Although plasma protein binding and absolute bioavailability of metaxalone are not known, the apparent volume of distribution (V/F ~ 800 L) and lipophilicity (log P = 2.42) of metaxalone suggest that the drug is extensively distributed in the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f06f2b96-3684-483c-89f7-6c9201fd4664 (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
sence of a high fat meal (Figure 1). 1 Distribution, Metabolism, and Excretion Although plasma protein binding and absolute bioavailability of metaxalone are not known, the apparent volume of distribution (V/F ~ 800 L) and lipophilicity (log P = 2.42) of metaxalone suggest that the drug is extensively distributed in the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8c3bc0a2-5c93-e1d6-e053-2995a90a0b83 (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
a high fat meal (Figure 1). [Figure 1] Distribution, Metabolism, and Excretion Although plasma protein binding and absolute bioavailability of metaxalone are not known, the apparent volume of distribution (V/F ~ 800 L) and lipophilicity (log P = 2.42) of metaxalone suggest that the drug is extensively distributed in the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:01199953-8124-4ace-947f-7b11989b44c3 (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Distribution, Metabolism, and Excretion Although plasma protein binding and absolute bioavailability of metaxalone are not known, the apparent volume of distribution (V/F ~ 800 L) and lipophilicity (log P = 2.42) of metaxalone suggest that the drug is extensively distributed in the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ee86f52c-fbf4-4882-bb7d-50220736fbb3 (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Distribution, Metabolism, and Excretion Although plasma protein binding and absolute bioavailability of metaxalone are not known, the apparent volume of distribution (V/F ~ 800 L) and lipophilicity (log P = 2.42) of metaxalone suggest that the drug is extensively distributed in the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9b7b4fc3-3f38-db66-e053-2995a90aaadb (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
a high fat meal (Figure 1). [Figure 1] Distribution, Metabolism, and Excretion Although plasma protein binding and absolute bioavailability of metaxalone are not known, the apparent volume of distribution (V/F ~ 800 L) and lipophilicity (log P = 2.42) of metaxalone suggest that the drug is extensively distributed in the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:91432cd0-8404-8029-e053-2a95a90adc1b (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
a high fat meal (Figure 1). [Figure 1] Distribution, Metabolism, and Excretion Although plasma protein binding and absolute bioavailability of metaxalone are not known, the apparent volume of distribution (V/F ~ 800 L) and lipophilicity (log P = 2.42) of metaxalone suggest that the drug is extensively distributed in the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4a558a2f-f9be-40d1-8d02-dd0c8c501ef6 (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Distribution, Metabolism, and Excretion Although plasma protein binding and absolute bioavailability of metaxalone are not known, the apparent volume of distribution (V/F ~ 800 L) and lipophilicity (log P = 2.42) of metaxalone suggest that the drug is extensively distributed in the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d0276e7b-a1c9-61f3-e053-2a95a90ae3aa (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Distribution, Metabolism, and Excretion Although plasma protein binding and absolute bioavailability of metaxalone are not known, the apparent volume of distribution (V/F ~ 800 L) and lipophilicity (log P = 2.42) of metaxalone suggest that the drug is extensively distributed in the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f05bb280-6736-4215-be5b-0e5f7991cd87 (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Mean (SD) Concentrations of Metaxalone following an 800 mg Dose under Fasted and Fed Conditions Distribution, Metabolism, and Excretion Although plasma protein binding and absolute bioavailability of metaxalone are not known, the apparent volume of distribution (V/F ~ 800 L) and lipophilicity (log P = 2.42) of metaxalone suggest that the drug is extensively distributed in the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:87518046-c959-d5f3-e053-2a95a90a5f7e (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Mean (SD) Concentrations of Metaxalone following an 800 mg Dose under fasted and Fed Conditions Distribution, Metabolism, and Excretion Although plasma protein binding and absolute bioavailability of metaxalone are not known, the apparent volume of distribution (V/F ~ 800 L) and lipophilicity (log P = 2.42) of metaxalone suggest that the drug is extensively distributed in the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9c7d0cd4-625a-485e-9d13-ce854630148c (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Distribution, Metabolism, and Excretion Although plasma protein binding and absolute bioavailability of metaxalone are not known, the apparent volume of distribution (V/F ~ 800 L) and lipophilicity (log P = 2.42) of metaxalone suggest that the drug is extensively distributed in the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fba1601d-3ac4-41cf-9548-35ec4994a95e (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
f a high fat meal (Figure 1). figure 1 Distribution, Metabolism, and Excretion Although plasma protein binding and absolute bioavailability of metaxalone are not known, the apparent volume of distribution (V/F ~ 800 L) and lipophilicity (log P = 2.42) of metaxalone suggest that the drug is extensively distributed in the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ef47682d-ea41-465e-aa21-cc773d45a6f0 (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Distribution, Metabolism, and Excretion Although plasma protein binding and absolute bioavailability of metaxalone are not known, the apparent volume of distribution (V/F ~ 800 L) and lipophilicity (log P = 2.42) of metaxalone suggest that the drug is extensively distributed in the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c2dd7071-cba3-410c-ade5-9d7e5af42038 (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Mean (SD) Concentrations of Metaxalone following an 800 mg Dose under fasted and Fed Conditions Distribution, Metabolism, and Excretion Although plasma protein binding and absolute bioavailability of metaxalone are not known, the apparent volume of distribution (V/F ~ 800 L) and lipophilicity (log P = 2.42) of metaxalone suggest that the drug is extensively distributed in the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:07ccff59-e335-40be-9e40-fd2d08197617 (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Distribution, Metabolism, and Excretion Although plasma protein binding and absolute bioavailability of metaxalone are not known, the apparent volume of distribution (V/F ~ 800 L) and lipophilicity (log P = 2.42) of metaxalone suggest that the drug is extensively distributed in the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:49250bbf-fbfe-07cd-e054-00144ff88e88 (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Mean (SD) Concentrations of Metaxalone Following an 800 mg Dose Under Fasted and Fed Conditions [Figure 1] Distribution, Metabolism and Excretion Although plasma protein binding and absolute bioavailability of metaxalone are not known, the apparent volume of distribution (V/F ~ 800 L) and lipophilicity (log P = 2.42) of metaxalone suggest that the drug is extensively distributed in the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:02c42f72-5d78-436d-8105-8c0f8d4c0d91 (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Distribution, Metabolism, and Excretion Although plasma protein binding and absolute bioavailability of metaxalone are not known, the apparent volume of distribution (V/F ~ 800 L) and lipophilicity (log P = 2.42) of metaxalone suggest that the drug is extensively distributed in the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b6afb4d3-eb3e-4e9f-9aa9-a44cfacb959c (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Distribution, Metabolism, and Excretion Although plasma protein binding and absolute bioavailability of metaxalone are not known, the apparent volume of distribution (V/F ~ 800 L) and lipophilicity (log P = 2.42) of metaxalone suggest that the drug is extensively distributed in the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b713a0f2-d47a-0ae7-e053-2995a90a5b85 (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
sence of a high fat meal (Figure 1) . Distribution, Metabolism, and Excretion Although plasma protein binding and absolute bioavailability of metaxalone are not known, the apparent volume of distribution (V/F ~ 800 L) and lipophilicity (log P = 2.42) of metaxalone suggest that the drug is extensively distributed in the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8aa84e64-0075-4f22-a576-da085f32d56c (opens source in a new tab)
Metaxalone label
Version not recorded · Effective date not recorded
Distribution, Metabolism, and Excretion Although plasma protein binding and absolute bioavailability of metaxalone are not known, the apparent volume of distribution (V/F ~ 800 L) and lipophilicity (log P = 2.42) of metaxalone suggest that the drug is extensively distributed in the tissues.
Projected row 953
- Medicine slug
- metformin
- Compared field
- halfLife
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 296
- Source count
- 287
- Agreement rate
- 1
- Recorded readings
6.2 hours
- Numeric value
- 6.2
- Unit
- hours
- Source records
- 287
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 287 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:07b4ee2a-8435-4d38-a6b0-b919e3424153 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:14f3091c-f243-4364-b433-727c7d4ef8d5 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:41a8bb80-7b0b-476c-8134-5d161c3239c8 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ef77c7dd-a65f-4adc-a0d9-a93779b459a0 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1d7556eb-82b4-4085-b0b1-dc061b216feb (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f9e78e0f-6a0a-4db3-bc09-5500748f9c84 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4e345b8c-57ab-4f09-9cbe-1d255e9354ba (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1f8833f9-1232-4aa7-a0d4-04a9f87dc2f0 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a57e2890-d83b-488c-b221-2e8f8a78ed16 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a59327bd-a3ba-417b-9e91-4cd3a941e640 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1ef6c527-89f5-4830-8900-7532b0a7ef26 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:242538d7-fb79-4df6-e063-6394a90a5b96 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:54ca16e6-1213-4877-8ace-477c764c8e76 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:33ecddbe-860a-6ca8-e063-6294a90aac64 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d43ccbc3-eb0b-400e-a6fa-31202dec3a71 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:73197cb5-3e23-4ac0-b189-f9bc848bce66 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c33e24e9-0441-6b94-e053-2a95a90a9c68 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:498ac5fc-14be-d36a-e063-6394a90a3012 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:388ee1e0-a0d2-324d-e063-6394a90a1664 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4e5a19c6-6ac6-ffc0-e063-6394a90a9827 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:836f3647-bfef-40d1-b475-c0d240241a67 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c0ff557c-fa50-46f6-aa77-36a4df354e80 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5269e91f-7e93-9405-e063-6294a90a3217 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7e41818c-60e9-4bcf-9586-7bb8d33d5e89 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2387a618-24d8-4813-aa83-9114edb35374 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:14450912-54b5-4fc3-ba65-77ece864b2e7 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:13235d8e-ac3a-45b4-9c5d-9a9012951dfe (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:46cb7e3f-c739-433d-9dbe-427c2d95bef1 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c1bfc7b5-c7e0-4353-b772-05d463c12886 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1200ea71-8a9e-4e49-bb77-7d9fe0d84ae7 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:74d32a8a-c4c2-4dbb-b376-eea3f8fa64d7 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:53361a39-cb69-483b-a4be-3a4753bf1ba6 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:76879512-3ab4-4acf-92e6-bba0fb75dd0e (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9c33414b-5dbb-4ce9-910b-9480d45e50ee (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3c607f04-d36f-4cf8-9cc9-7f2af08b4098 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1e298db3-439e-4e91-8f9e-01c3cdc4d552 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7cc82387-8bb0-4bee-9967-cb13eab1d801 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:33155746-c2ef-12f4-e063-6294a90a039c (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9fed67ea-7a15-4634-80cf-c975b8812ebe (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:23aa50c5-28fe-4322-b5c6-1f1c48409b16 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e1ebb146-acfd-4301-a79c-f5bb243f8575 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c568d49f-c040-4f1e-ad36-77b05ab659c3 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c3dfa8a1-d10a-4a1a-8eba-5f4e2a5a2949 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:104b5f5b-cc83-450d-82ec-1fd20c4f7119 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:53bde438-4277-f418-e063-6394a90a5ea2 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a944a167-e3ac-4084-af1c-22b48713471c (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:17050df5-9e95-4e1b-ac75-34add289b139 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5d8d654a-9bb4-4c87-ab43-c21c4e874708 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:59a4ccda-5487-4ac4-9373-0c0fc8b7c88b (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:55062171-7581-0630-e063-6394a90ac088 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9171d369-d35a-40e4-a9ad-26484e66fc5e (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3d450933-8d9d-27de-e063-6294a90ae6d9 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e55ee270-5eb9-4848-8529-9af2a79669c0 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:439bb230-94d8-4522-ad79-5cce5fad965b (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:93b0878d-b039-4479-8315-6dabf7e70611 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5c2581e3-2b30-4da5-8bed-228173ca20d2 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2d2ebf52-3d5e-4fad-b7f7-c9280957574c (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4ba2a76f-6665-4012-84e4-f2849a0246ac (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:df61d56e-18ff-404c-b671-42b39aa23574 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0f251f2c-97f3-4048-84f2-81fea03685aa (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4adeddf2-f449-4a61-9658-dfbff7c50230 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a434b937-2648-4509-8ce8-94a28582ec77 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ec3a9070-3745-41fb-b610-8d06129d8fd9 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bb62088f-e9af-4644-9f57-cb90bab0f199 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3eeee3b7-188a-05a0-e063-6294a90a1853 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3edc9b51-ddee-61f8-e063-6294a90ad3c5 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:623b3bc6-1b07-4a04-bc7a-7fc695adf063 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:21cbb326-9dee-40ec-ac25-0dad79e3302b (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:403349a1-ec19-8982-e063-6294a90aa060 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:235680e6-1c3e-45b8-902e-866583f1aef3 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f39ee08d-73db-71b9-e053-2995a90a877c (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0ef9de1a-b786-4b6c-a250-3f5ac532b16a (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6864ff5a-7512-4a4f-ad26-b2b9c5843414 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:75b25738-31e6-4b58-9d2b-f4a1ab4ab090 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:583dac53-65e7-4710-912a-ecd89d07ad03 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:60142fb2-16da-4f54-a542-74f9a70b9c8b (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:738402d6-3700-46b2-a90c-2e8f2c354a39 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:11d52559-bfde-4c2a-9602-f18fb3187617 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5647230e-5bc6-1802-e063-6394a90a2724 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4ac6d01a-af26-44e7-ae2e-3618de0080aa (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1d0b74de-ef4c-4dd2-8019-2ddb409c60b4 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5866ca12-a28f-cbe7-e063-6294a90acc69 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:49a0b5c2-ebaf-4c4c-905f-dfd1962ac647 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bfd6ec0f-8264-4877-aa6d-f347f53bc426 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:72dbc087-9a84-4126-bf54-c5254a8b129c (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d80aa4af-a8ce-4cae-b71c-05e1de829551 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4d89a4ab-6cdd-4c39-92f9-a137fa27a070 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:86627ff4-da1c-429d-991b-88e97f6967d6 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c2783b59-7b20-4d4c-a3ca-03ed60dcf2c3 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:38687872-ca68-4965-b317-637c25ba041e (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:32d6c5f4-0116-4e38-b179-e1967ae63e66 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5bb945c1-954a-4d43-aa24-33767d19c57c (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fc61bafa-a506-14ae-e053-6394a90a9c7d (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0b3d7c79-9a5a-a82e-e063-6394a90a3caa (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:de4a660b-172b-4c72-9e38-5634fd03cfa7 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:32ff33ed-89ed-c391-e063-6294a90ae414 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3890b116-7c3c-e48e-e063-6294a90a0c8a (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a5980bc8-8de8-c456-e053-2a95a90a792e (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b63bfafa-db4c-4fb8-84cd-ff73a5e7d320 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e3e9b582-fd15-4fe0-a210-398d9149696e (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:542cec22-eeae-4704-9bb6-4176640e5ea8 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5f2023d2-05ae-489d-9e18-fb75057496bc (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:07d8a69f-30d9-7511-e063-6394a90a95ca (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:be023bca-511e-4801-bd2b-e30dd1408772 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4f70f907-08d5-4c2e-a4be-32c6124faa7b (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f4fc759a-057e-4b5d-b8ab-13bc5eeb24e4 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2a84c550-aed8-4058-961f-351a5e4cf7a1 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6d9179a8-9579-4804-a4c7-633f37aef1ee (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:552df462-6dcb-e6f2-e063-6294a90aacfe (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9eebed09-2562-4d21-b3b3-c06562fe3f99 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:928ef685-80cb-42a9-a155-3c21c9b1dd67 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4d3dbf6f-1c8a-4daa-8343-8cd8f64a65cd (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:13b1e35f-d047-8ddc-e063-6394a90a24dd (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1503bbe4-0ac5-479b-9900-d38e49236bf0 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:58bec665-b648-6baf-e063-6394a90a1cbb (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fb296500-55cb-45ce-be0c-59aa2e3d4624 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d8bd1779-d1c4-4dde-816d-ea72b37bb5cd (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:25be863d-490c-47f6-9ad3-c828dc43fbf0 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4182bcf0-1f9a-4f3a-9428-86b5d757954f (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4f5389d2-dbcf-4fcb-9048-05953eb1fb05 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fb90693a-074a-45be-94f4-ed6298b1f4e4 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f5ef117c-27ff-c21e-e053-2995a90ae145 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:dfac4d9c-2f20-417c-a1be-4f1c2738f351 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:64650d2c-2bec-4470-b250-29d01caa1ebe (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8c7835fa-3f68-4850-b1da-34893bafb485 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0cd086d6-3ae2-476e-b93e-29055e67e8fc (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4670d280-53c3-4c51-b3c5-26d71e47bddc (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6f6118c1-cecc-4d7b-9965-7b114a1ad56b (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8ce6b615-2abd-4a5b-997b-11aa1aec142d (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d0bc43a4-301f-4002-9b58-bd81dddf2790 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:74f18a3e-0f5c-4172-b499-14f229b431c4 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1ebaab3a-3d62-4c36-853f-c8784993eafb (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a79d2674-071f-4641-9b11-406e02c5530a (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a4679179-af2d-4c84-a1c8-ab0870a4585d (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9632456f-57c2-444b-9f43-d9ca862681fe (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:34aa1761-d16f-4bfc-b7fa-bf1b0387e8a3 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:041632fa-9bf4-8d7c-e063-6294a90adefb (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f6581ce6-0f9f-4887-ae83-4c6ecde619f3 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:390c3bdf-bfaf-203e-e063-6394a90a7d20 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bf918d78-3fb6-4d8d-b42d-538ea10bc3e4 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ded33248-44ef-45f6-a461-24b35772a1b2 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4be72741-4f6d-6689-e054-00144ff8d46c (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:397c2bf4-35be-4e75-b5a6-426e3fa09548 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ca71c133-6c38-4b9e-80af-1949634157f4 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f31c08fc-cda1-349c-e053-2a95a90aba15 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:239834b0-121a-4903-b3ee-90bb4db4753b (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4aa880a4-7ec0-9155-e063-6394a90a8f3e (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0178b9dd-bafa-9e81-e063-6294a90a88b0 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:abd0dad9-5f29-4102-a099-dce7bdddb98b (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0448c618-2f0d-4ed3-866f-74b413cf902d (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b8004451-7b26-425b-b5ea-cbb1b08e30e3 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d2c927eb-12bf-4c7d-9ef5-0036b2dd8c29 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5e783025-bf6d-465e-bf58-bcd253afad2c (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fc466c46-abaa-4675-aef2-4b1a1adfd912 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d5228e81-9c86-4781-b984-20feaa2ae779 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e22a8545-86a6-439e-a758-29c4d6ed8bfe (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:dae7b1c1-7ff1-883c-e053-2a95a90a1a2b (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:103080cb-6381-44f6-8a31-1fc81e7c890f (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7cb47c3e-6657-4c11-8aa2-ae172e5a8529 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:474e2900-43bf-4ebe-9d29-4a7adb8a9429 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d51f3618-4166-4925-8994-968a653ebc46 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4bdd2faa-2125-4139-b958-196393e31b7e (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0710e208-5b2c-3c72-e063-6394a90a4dac (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1aa40000-877f-8ea4-e063-6394a90a0e31 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:192970d3-826a-4b69-a525-9742794dc19c (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1d8b8970-c2a1-4780-be87-ab8ccfd401fa (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0e7b02cc-2ddc-4394-a80c-128e6452d697 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:33550b88-d4bb-4ce6-a7db-07c966f6984f (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fb890205-5d43-41eb-97b2-fb0dcdd3a950 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1016cad7-2198-483c-893b-e25fd397a226 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:41408f64-d366-403e-9595-464ab25c6f97 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4d087f00-580b-4b9d-80d9-f97930153e72 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3cbb802d-d493-255e-e063-6294a90a32f2 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:53ba7031-be87-47a5-ade7-494c6c489cc6 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f86bda10-8b25-4125-8bb1-1b5917969ff0 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4e4c4ba9-65c6-4273-8f6b-2423ab521dad (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d5dbf0d9-9673-4aae-9e28-da9b90bac038 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d60139c2-fd35-4ab4-af7e-7410481edc2e (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1182bf60-3578-a0ed-e063-6394a90aa50f (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1c046303-993c-4111-ac9a-40a0d97ca6a2 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6b8824c0-ece0-4b15-ba71-e893d6d2bfdf (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2737f784-07ad-4e5a-862f-beaea31d005e (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:011de1a5-1ac0-4831-9e8d-26ec79ba2205 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6a9ab61a-a5d0-41ef-b528-59eac6b4cfe6 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c2bbaa0c-5b05-4335-882f-14f1b443edd7 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:286d959a-51cb-4dbd-a3e8-1ea2f00b54c7 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0b3d5420-d60c-8385-e063-6394a90abb6c (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:356b02d0-d239-4441-bb33-c4c54166fcd7 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3ba957ea-28ed-4a61-a318-98064ea4944d (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:273d86b0-9d30-48c9-8918-c5e1ececa951 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f59ceea4-a84a-4082-8e73-7c6f340c28d6 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:23aa0072-365c-4d13-9aa7-ae23f7e00ee4 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:05d4df4b-dfe8-4828-b423-a3d4f2c4114a (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:51285096-e2ce-0f3c-e063-6394a90a35d4 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1e7ab8da-4ece-499c-b0fb-34e37d991c1c (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0ff1ba75-3c86-4baf-a6b1-1bb883839866 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b090b18b-b53c-4c92-892f-d11551cfedc3 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c8e50300-1838-4c51-8d9d-ebbaaf0f3991 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c82a10fa-1e8e-46b6-890a-737de3f34ee1 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:583f2a2e-a9d7-f266-e063-6294a90ad0ab (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f55a245b-a786-4a4a-b11c-c61d48294b01 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:93c8deae-3103-4cbf-a5d1-fe0d37e76df8 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2d98aea3-35ba-447a-b88f-a5a20b612b2f (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:59743092-bae1-4725-ac4b-c8a8b0a81c1e (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e087ce3b-8d7f-43a3-8d20-54513da7617d (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d0bee456-c8cd-46a1-acb3-5313a8cddd30 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5f243894-bda3-4fa9-97e4-209dcb389dee (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:88af3365-1145-45a1-ab0f-1c794f0c13db (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2be73d5e-7682-4ad3-831b-8c1ea73e38de (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:dd54d30b-9390-4e5a-bf62-fbf18b91e4cd (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:242256af-c587-060a-e063-6294a90a68cc (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:dac78f8d-67f9-41d5-9540-39cae34f3a98 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0865f83f-0f34-0690-e063-6294a90abf04 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4db5551b-04f6-4921-9dee-68acb41f7f71 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:51e1fe6e-a7fa-47a5-bbd5-73b275230c7f (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3982b985-9184-0e17-e063-6394a90aae05 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3ac4e864-4b8a-13b1-e063-6294a90ada66 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:056072d8-6228-4914-831d-ee7c0661b742 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c72cfd1a-dce9-43a3-88e2-3cf1d9078b52 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fb832474-88d9-4e29-95cd-fbc446944cc4 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:37ff1b8e-a434-41c0-82e1-4583842921a5 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:06ade2e1-5981-4e3d-b7e9-7ff083eb4551 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:de09f7a1-1e9f-60f4-e053-2a95a90a93d8 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d9bac244-1725-5bf3-e053-2a95a90ac823 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ab80521b-5014-cc2a-e053-2a95a90a2003 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b51da8d7-ab4a-4c40-97c9-88bd379366d1 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:db113f46-6fac-9005-e053-2995a90a017a (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:014f2a32-8440-4d0c-8f5d-c4b3a49e0dec (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:27f603ec-25e6-4270-a7a3-34a64a76f7ef (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:902d1bc4-3f1f-4a1a-86d7-cf98c56a3684 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8d4b8620-5e99-4d12-b4f2-e9967b627b57 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5aa1c86c-f2c8-49b1-8f81-47b11386c5d3 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cc070735-5e8d-4bb3-9caa-e84d29bb8943 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1e8136e0-cc98-41e4-ad4b-a8fc27fb4daa (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:073cf6d9-7142-4d8b-898e-174c62a1f76f (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5538e9df-0983-9281-e063-6394a90a9249 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f2a27d7a-ade4-421f-e053-2a95a90a01a9 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c37b511c-1e33-4941-bd12-df0447a50ca9 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5df6adc9-79fd-66ef-e053-2991aa0a75ce (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:129ff158-097f-401a-8924-d9258465c1f3 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1a047fc0-196e-79af-e063-6394a90a1e0d (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:565610b8-a9a0-4e5e-866d-81d9501a817d (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:289dc8ec-42c8-1d09-e063-6394a90a97f0 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2d7d9364-e71d-4ef6-e063-6394a90af841 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2d68fd88-c591-4577-a7c3-901338bdaf90 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:784a6bbd-4f13-45ed-89c1-154b06721ed0 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0230a3c3-34cf-478b-88c3-4d96e5300018 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5073c482-952c-400c-afff-64380f133bc8 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4d4021ba-4b28-6b81-e063-6294a90a5ea7 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d1d7204a-7e8a-4f76-bf9f-3e798c2632ba (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:53e950f5-c58f-78e3-e063-6294a90a53e9 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:400ff9dc-9789-44ac-afb5-730b632a1667 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:62ca8af4-ff91-4bf6-b7c6-895b3b5ce8c3 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:552ad61d-bafd-478d-e063-6294a90a02f9 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:68d0b1a6-c99e-42cf-afdf-b71ee73c4424 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:dc65065b-cba0-46d7-8fb5-3368f3210b4d (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:30658e19-8e6e-49aa-a007-e414224797c5 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e18b60f9-721e-4db6-9f61-d3437e18faf2 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:082b4de9-e452-fe71-e063-6394a90ac863 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination halflife of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3ab4efb6-bd30-2583-e063-6294a90a415b (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:52eecdbd-e07e-447f-bf38-b3c347b60662 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:33ec9f6e-16d9-40ba-e063-6294a90ae87b (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1a7f7ef3-a94b-4ff6-a9f2-f5de4a99c7f6 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1b9b6db9-1bac-4252-a03c-18dc0271f05f (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:afb183f6-a13c-4f00-82d5-9fe336173d34 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ed6e6f87-ddd7-4c9d-a263-47154d3a9478 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:21b76183-af30-e06f-e063-6394a90a9653 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:73691c6c-8841-4c5d-b4a5-c3ed3b5effa1 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:27d6fdbc-27a8-c599-e063-6394a90a2233 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a2385bcd-0943-4411-8658-c22b50360385 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7cc02a26-5c22-445b-ad8f-3e7570c143d3 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:dd0ee2bf-f658-42dc-976d-49af0b1f32b5 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2ffeb25a-76a9-01e6-e063-6394a90ae332 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f2318509-9a49-4c99-a08b-22381f17aacd (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1ed9dde4-339c-486f-a346-dde33a5e493f (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8c248958-6c01-455e-89f5-959facb272ed (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3ab005d4-bc99-4fdb-e063-6394a90a5124 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c01a79e0-f2b7-4d99-857e-bda7f24fe319 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1cb2b2be-595c-4e72-8d2c-c1edc7f85682 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4d245bc3-0add-4651-b441-86b93c5ac681 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:14238afd-200d-4a05-b731-647c43cecbc3 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3dca884d-ec44-496f-9eeb-31fd8fa3f574 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:85027e6c-d35b-49eb-a234-dd71aa77aee0 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d09a2eda-fdd8-44ed-8e2f-ea91ddfd3c68 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8cd5555c-f6b2-28d8-e053-2a95a90a5f1e (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a9e7608f-540c-d90c-e053-2a95a90a4f98 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8c1848f9-c113-4552-b6ef-715e72630ad9 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.
Projected row 954
- Medicine slug
- metformin
- Compared field
- proteinBinding
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 296
- Source count
- 32
- Agreement rate
- 1
- Recorded readings
90%
- Numeric value
- 90
- Unit
- %
- Source records
- 32
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 32 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4e345b8c-57ab-4f09-9cbe-1d255e9354ba (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Metformin is negligibly bound to plasma proteins, in contrast to sulfonylureas, which are more than 90% protein bound.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1f8833f9-1232-4aa7-a0d4-04a9f87dc2f0 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Metformin is negligibly bound to plasma proteins, in contrast to sulfonylureas, which are more than 90% protein bound.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d43ccbc3-eb0b-400e-a6fa-31202dec3a71 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Metformin is negligibly bound to plasma proteins, in contrast to sulfonylureas, which are more than 90% protein bound.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:53361a39-cb69-483b-a4be-3a4753bf1ba6 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Metformin is negligibly bound to plasma proteins, in contrast to sulfonylureas, which are more than 90% protein bound.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5c2581e3-2b30-4da5-8bed-228173ca20d2 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Metformin is negligibly bound to plasma proteins, in contrast to sulfonylureas, which are more than 90% protein bound.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4ba2a76f-6665-4012-84e4-f2849a0246ac (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Metformin is negligibly bound to plasma proteins, in contrast to sulfonylureas, which are more than 90% protein bound.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:21cbb326-9dee-40ec-ac25-0dad79e3302b (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Metformin is negligibly bound to plasma proteins, in contrast to sulfonylureas, which are more than 90% protein bound.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:235680e6-1c3e-45b8-902e-866583f1aef3 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Metformin is negligibly bound to plasma proteins, in contrast to sulfonylureas, which are more than 90% protein bound.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0b3d7c79-9a5a-a82e-e063-6394a90a3caa (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Metformin is negligibly bound to plasma proteins, in contrast to sulfonylureas, which are more than 90% protein bound.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:552df462-6dcb-e6f2-e063-6294a90aacfe (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Metformin is negligibly bound to plasma proteins, in contrast to sulfonylureas, which are more than 90% protein bound.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:13b1e35f-d047-8ddc-e063-6394a90a24dd (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Metformin is negligibly bound to plasma proteins, in contrast to sulfonylureas, which are more than 90% protein bound.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6f6118c1-cecc-4d7b-9965-7b114a1ad56b (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Metformin is negligibly bound to plasma proteins, in contrast to sulfonylureas, which are more than 90% protein bound.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:74f18a3e-0f5c-4172-b499-14f229b431c4 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Metformin is negligibly bound to plasma proteins, in contrast to sulfonylureas, which are more than 90% protein bound.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ded33248-44ef-45f6-a461-24b35772a1b2 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Metformin is negligibly bound to plasma proteins, in contrast to sulfonylureas, which are more than 90% protein bound.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4be72741-4f6d-6689-e054-00144ff8d46c (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Metformin is negligibly bound to plasma proteins, in contrast to sulfonylureas, which are more than 90% protein bound.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:397c2bf4-35be-4e75-b5a6-426e3fa09548 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Metformin is negligibly bound to plasma proteins, in contrast to sulfonylureas, which are more than 90% protein bound.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d2c927eb-12bf-4c7d-9ef5-0036b2dd8c29 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Metformin is negligibly bound to plasma proteins, in contrast to sulfonylureas, which are more than 90% protein bound.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4bdd2faa-2125-4139-b958-196393e31b7e (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Metformin is negligibly bound to plasma proteins, in contrast to sulfonylureas, which are more than 90% protein bound.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fb890205-5d43-41eb-97b2-fb0dcdd3a950 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Metformin is negligibly bound to plasma proteins, in contrast to sulfonylureas, which are more than 90% protein bound.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3ba957ea-28ed-4a61-a318-98064ea4944d (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Metformin is negligibly bound to plasma proteins, in contrast to sulfonylureas, which are more than 90% protein bound.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:273d86b0-9d30-48c9-8918-c5e1ececa951 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Metformin is negligibly bound to plasma proteins, in contrast to sulfonylureas, which are more than 90% protein bound.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:23aa0072-365c-4d13-9aa7-ae23f7e00ee4 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Metformin is negligibly bound to plasma proteins, in contrast to sulfonylureas, which are more than 90% protein bound.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c8e50300-1838-4c51-8d9d-ebbaaf0f3991 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Metformin is negligibly bound to plasma proteins, in contrast to sulfonylureas, which are more than 90% protein bound.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2d98aea3-35ba-447a-b88f-a5a20b612b2f (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Metformin is negligibly bound to plasma proteins, in contrast to sulfonylureas, which are more than 90% protein bound.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:242256af-c587-060a-e063-6294a90a68cc (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Metformin is negligibly bound to plasma proteins, in contrast to sulfonylureas, which are more than 90% protein bound.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:dac78f8d-67f9-41d5-9540-39cae34f3a98 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Metformin is negligibly bound to plasma proteins, in contrast to sulfonylureas, which are more than 90% protein bound.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:06ade2e1-5981-4e3d-b7e9-7ff083eb4551 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Metformin is negligibly bound to plasma proteins, in contrast to sulfonylureas, which are more than 90% protein bound.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5538e9df-0983-9281-e063-6394a90a9249 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Metformin is negligibly bound to plasma proteins, in contrast to sulfonylureas, which are more than 90% protein bound.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c37b511c-1e33-4941-bd12-df0447a50ca9 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Metformin is negligibly bound to plasma proteins, in contrast to sulfonylureas, which are more than 90% protein bound.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5df6adc9-79fd-66ef-e053-2991aa0a75ce (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Metformin is negligibly bound to plasma proteins, in contrast to sulfonylureas, which are more than 90% protein bound.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1b9b6db9-1bac-4252-a03c-18dc0271f05f (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Metformin is negligibly bound to plasma proteins, in contrast to sulfonylureas, which are more than 90% protein bound.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:21b76183-af30-e06f-e063-6394a90a9653 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
Metformin is negligibly bound to plasma proteins, in contrast to sulfonylureas, which are more than 90% protein bound.
Projected row 955
- Medicine slug
- metformin
- Compared field
- tMax
- Comparison state
- insufficient_context
- Reason codes
- STRUCTURED_CONTEXT_MISSING
- Documents examined
- 296
- Source count
- 19
- Agreement rate
- 0.578947
- Recorded readings
7 to 8 hours
- Numeric value
- 7
- Unit
- hours
- Source records
- 11
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 11 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:73197cb5-3e23-4ac0-b189-f9bc848bce66 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Following a single oral dose of 1,000 mg (2x500 mg tablets) metformin hydrochloride extended-release tablets after a meal, the time to reach maximum plasma metformin concentration (T max ) is achieved at approximately 7 to 8 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1200ea71-8a9e-4e49-bb77-7d9fe0d84ae7 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Following a single oral dose of 1,000 mg (2x500 mg tablets) metformin hydrochloride extended-release tablets after a meal, the time to reach maximum plasma metformin concentration (T max ) is achieved at approximately 7 to 8 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:74d32a8a-c4c2-4dbb-b376-eea3f8fa64d7 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Following a single oral dose of 1,000 mg (2x500 mg tablets) Metformin Hydrochloride Extended-Release Tablets after a meal, the time to reach maximum plasma metformin concentration (T max ) is achieved at approximately 7-8 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:104b5f5b-cc83-450d-82ec-1fd20c4f7119 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Following a single oral dose of 1,000 mg (2x500 mg tablets) metformin hydrochloride extended-release tablets after a meal, the time to reach maximum plasma metformin concentration (T max ) is achieved at approximately 7 to 8 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0ef9de1a-b786-4b6c-a250-3f5ac532b16a (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Following a single oral dose of 1,000 mg (2x500 mg tablets) metformin hydrochloride extended-release tablets after a meal, the time to reach maximum plasma metformin concentration (T max ) is achieved at approximately 7 to 8 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a5980bc8-8de8-c456-e053-2a95a90a792e (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Following a single oral dose of 1,000 mg (2x500 mg tablets) metformin hydrochloride extended-release tablets after a meal, the time to reach maximum plasma metformin concentration (T max ) is achieved at approximately 7 to 8 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1016cad7-2198-483c-893b-e25fd397a226 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Following a single oral dose of 1,000 mg (2x500 mg tablets) metformin hydrochloride extended-release tablets after a meal, the time to reach maximum plasma metformin concentration (T max ) is achieved at approximately 7-8 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2737f784-07ad-4e5a-862f-beaea31d005e (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Following a single oral dose of 1,000 mg (2 x 500 mg tablets) metformin hydrochloride extended-release tablets after a meal, the time to reach maximum plasma metformin concentration (T max ) is achieved at approximately 7-8 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fb832474-88d9-4e29-95cd-fbc446944cc4 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Following a single oral dose of 1,000 mg (2x500 mg tablets) GLUMETZA after a meal, the time to reach maximum plasma metformin concentration (Tmax) is achieved at approximately 7-8 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cc070735-5e8d-4bb3-9caa-e84d29bb8943 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Following a single oral dose of 1,000 mg (2x500 mg tablets) metformin hydrochloride extended-release tablets after a meal, the time to reach maximum plasma metformin concentration (T max ) is achieved at approximately 7 to 8 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:129ff158-097f-401a-8924-d9258465c1f3 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Following a single oral dose of 1,000 mg (2x500 mg tablets) metformin hydrochloride extended-release tablets after a meal, the time to reach maximum plasma metformin concentration (T max ) is achieved at approximately 7-8 hours.
2.5 hours
- Numeric value
- 2.5
- Unit
- hours
- Source records
- 7
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 7 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:df61d56e-18ff-404c-b671-42b39aa23574 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
The mean t max was 2.5 hours under fasting conditions as compared to 3.9 hours with both low fat/ low calorie meal and high fat/high calorie meals (see Table 4).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fb90693a-074a-45be-94f4-ed6298b1f4e4 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
The mean t max was 2.5 hours under fasting conditions as compared to 3.9 hours with both low fat/ low calorie meal and high fat/high calorie meals (see Table 4).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:05d4df4b-dfe8-4828-b423-a3d4f2c4114a (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
The mean t max was 2.5 hours under fasting conditions as compared to 3.9 hours with both low fat/ low calorie meal and high fat/high calorie meals (see Table 4).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e087ce3b-8d7f-43a3-8d20-54513da7617d (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
The mean t max was 2.5 hours under fasting conditions as compared to 3.9 hours with both low fat/ low calorie meal and high fat/high calorie meals (see Table 4).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:73691c6c-8841-4c5d-b4a5-c3ed3b5effa1 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
The mean t max was 2.5 hours under fasting conditions as compared to 3.9 hours with both low fat/ low calorie meal and high fat/high calorie meals (see Table 4).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7cc02a26-5c22-445b-ad8f-3e7570c143d3 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
The mean t max was 2.5 hours under fasting conditions as compared to 3.9 hours with both low fat/ low calorie meal and high fat/high calorie meals (see Table 4).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3ab005d4-bc99-4fdb-e063-6394a90a5124 (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
The mean t max was 2.5 hours under fasting conditions as compared to 3.9 hours with both low fat/ low calorie meal and high fat/high calorie meals (see Table 4).
7 hours
- Numeric value
- 7
- Unit
- hours
- Source records
- 1
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 1 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1ed9dde4-339c-486f-a346-dde33a5e493f (opens source in a new tab)
Metformin label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Following a single oral dose of 1,000 mg (2x500 mg tablets) metformin hydrochloride extended-release tablets after a meal, the time to reach maximum plasma metformin concentration (T max ) is achieved at approximately 7 hours to 8 hours.
Projected row 956
- Medicine slug
- methadone
- Compared field
- bioavailability
- Comparison state
- insufficient_context
- Reason codes
- STRUCTURED_CONTEXT_MISSING
- Documents examined
- 36
- Source count
- 32
- Agreement rate
- 0.5625
- Recorded readings
36 to 100%
- Numeric value
- 36
- Unit
- %
- Source records
- 18
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 18 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:50f14803-78c0-4d19-8b5d-9a9c17582ac1 (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Following oral administration the bioavailability of methadone ranges between 36 to 100% and peak plasma concentrations are achieved between 1 to 7.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:540edd43-165d-4257-b989-3bccc8f54afb (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Following oral administration the bioavailability of methadone ranges between 36 to 100% and peak plasma concentrations are achieved between 1 to 7.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c54baaee-8ea4-45f5-a5c8-bb84cf86832f (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption: Following oral administration the bioavailability of methadone ranges between 36 to 100% and peak plasma concentrations are achieved between 1 to 7.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4c8b541c-33e8-4969-b258-af150808d46e (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Following oral administration the bioavailability of methadone ranges between 36 to 100% and peak plasma concentrations are achieved between 1 to 7.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6da7501b-b881-4bc7-891a-74214a00a3ac (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Following oral administration the bioavailability of methadone ranges between 36 to 100% and peak plasma concentrations are achieved between 1 to 7.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f0366917-f745-4b01-a662-a98a7d80b4a0 (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Following oral administration the bioavailability of methadone ranges between 36 to 100% and peak plasma concentrations are achieved between 1 to 7.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:544483e6-6f9d-4371-9e93-313e54e0ea05 (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Following oral administration the bioavailability of methadone ranges between 36 to 100% and peak plasma concentrations are achieved between 1 to 7.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6984eb5a-57a3-4686-bc67-91bc3e7a531e (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Following oral administration, the bioavailability of methadone ranges between 36 to 100% and peak plasma concentrations are achieved between 1 to 7.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d702d32b-98b1-412d-934c-1cd96af4b95a (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Following oral administration the bioavailability of methadone ranges between 36 to 100% and peak plasma concentrations are achieved between 1 to 7.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1a536622-dda3-41af-ab08-28e7c1bc9300 (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Following oral administration the bioavailability of methadone ranges between 36 to 100% and peak plasma concentrations are achieved between 1 to 7.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7a8635fe-6183-4cda-9029-50e4e6dd5832 (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption: Following oral administration the bioavailability of methadone ranges between 36 to 100% and peak plasma concentrations are achieved between 1 to 7.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:db52fdc0-765a-4fad-a8f9-ef98c6e4b898 (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Following oral administration the bioavailability of methadone ranges between 36 to 100% and peak plasma concentrations are achieved between 1 to 7.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d7b30c78-c531-4dc5-9552-d68daa3210d1 (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
Pharmacokinetics Absorption Following oral administration the bioavailability of methadone ranges between 36 to 100% and peak plasma concentrations are achieved between 1 and 7.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:eddf7077-02fb-4771-9823-31984f4ff2bb (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Following oral administration the bioavailability of methadone ranges between 36 to 100% and peak plasma concentrations are achieved between 1 to 7.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e6af84de-cbfc-4a3b-bd73-6bcf77337168 (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption: Following oral administration the bioavailability of methadone ranges between 36 to 100% and peak plasma concentrations are achieved between 1 to 7.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7ff89589-149c-4007-8144-5f60131b8c33 (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Following oral administration the bioavailability of methadone ranges between 36 to 100% and peak plasma concentrations are achieved between 1 to 7.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4a44bde6-c348-4316-b0e0-c24b407cb823 (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Following oral administration the bioavailability of methadone ranges between 36 to 100% and peak plasma concentrations are achieved between 1 to 7.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8f4cf84e-165c-489d-a668-0f715053f196 (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Following oral administration the bioavailability of methadone ranges between 36 to 100% and peak plasma concentrations are achieved between 1 to 7.5 hours.
36%
- Numeric value
- 36
- Unit
- %
- Source records
- 14
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 14 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:714e5adb-bdce-4dff-99aa-4ac3a2f3a0fe (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Following oral administration the bioavailability of methadone ranges between 36% to 100% and peak plasma concentrations are achieved between 1 and 7.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d5bd3e97-b3f6-4bc2-9fb7-02921be35cdb (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Following oral administration the bioavailability of methadone ranges between 36% to 100% and peak plasma concentrations are achieved between 1 and 7.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f9dad5d5-3417-4992-99ee-6550f81add6b (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Following oral administration the bioavailability of methadone ranges between 36% to 100% and peak plasma concentrations are achieved between 1 and 7.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:14f7b1d8-344a-4eaa-a1bf-bc1a00c3ab58 (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Following oral administration the bioavailability of methadone ranges between 36% to 100% and peak plasma concentrations are achieved between 1 and 7.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e980d666-d74d-4358-a3b7-c6accb15eba6 (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption : Following oral administration the bioavailability of methadone ranges between 36% to 100% and peak plasma concentrations are achieved between 1 to 7.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f935effe-e5b2-4bf7-bbde-6e80bb99076f (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption : Following oral administration the bioavailability of methadone ranges between 36% to 100% and peak plasma concentrations are achieved between 1 to 7.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e72841bf-364b-49b1-8e69-7e26ddcd2657 (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Following oral administration the bioavailability of methadone ranges between 36% to 100% and peak plasma concentrations are achieved between 1 and 7.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d0e6a966-179a-45e0-8444-4c1b8523f8d2 (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Following oral administration, the bioavailability of methadone ranges between 36% to 100% and peak plasma concentrations are achieved between 1 to 7.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cbc42334-8783-4572-b8da-8c7451d14077 (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption: Following oral administration the bioavailability of methadone ranges between 36% to 100% and peak plasma concentrations are achieved between 1 to 7.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:808a9d0b-720b-4034-a862-5122ff514608 (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Following oral administration the bioavailability of methadone ranges between 36% to 100% and peak plasma concentrations are achieved between 1 and 7.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0955ea4a-c6b8-431f-ba42-9641b5b102ea (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Following oral administration the bioavailability of methadone ranges between 36% to 100% and peak plasma concentrations are achieved between 1 and 7.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5baef1bf-8bf0-429c-a4ce-1c93171f3f15 (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Following oral administration the bioavailability of methadone ranges between 36% to 100% and peak plasma concentrations are achieved between 1 to 7.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:373c649e-798d-770e-e063-6294a90a6e47 (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Following oral administration the bioavailability of methadone ranges between 36% to 100% and peak plasma concentrations are achieved between 1 and 7.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8c363f90-c378-48ae-abbc-aeb25c9bf5cb (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Following oral administration the bioavailability of methadone ranges between 36% to 100% and peak plasma concentrations are achieved between 1 to 7.5 hours.
Projected row 957
- Medicine slug
- methadone
- Compared field
- halfLife
- Comparison state
- insufficient_context
- Reason codes
- STRUCTURED_CONTEXT_MISSING
- Documents examined
- 36
- Source count
- 35
- Agreement rate
- 0.742857
- Recorded readings
8 to 59 hours
- Numeric value
- 8
- Unit
- hours
- Source records
- 26
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 26 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:50f14803-78c0-4d19-8b5d-9a9c17582ac1 (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
Published reports indicate that after multiple dose administration the apparent plasma clearance of methadone ranged between 1.4 and 126 L/h, and the terminal half-life (T 1/2 ) was highly variable and ranged between 8 to 59 hours in different studies.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:540edd43-165d-4257-b989-3bccc8f54afb (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
Published reports indicate that after multiple dose administration the apparent plasma clearance of methadone ranged between 1.4 and 126 L/h, and the terminal half-life (T 1/2 ) was highly variable and ranged between 8 to 59 hours in different studies.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c54baaee-8ea4-45f5-a5c8-bb84cf86832f (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
Published reports indicate that after multiple dose administration the apparent plasma clearance of methadone ranged between 1.4 and 126 L/h, and the terminal half-life (T 1/2 ) was highly variable and ranged between 8 to 59 hours in different studies.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4c8b541c-33e8-4969-b258-af150808d46e (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
Published reports indicate that after multiple dose administration the apparent plasma clearance of methadone ranged between 1.4 and 126 L/h, and the terminal half-life (T 1/2 ) was highly variable and ranged between 8 to 59 hours in different studies.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:13541167-95f4-4cb9-9d7d-3c1aced5c5f6 (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
After single intravenous dose administration the plasma clearance of methadone ranged between 3 L/h to 10 L/h and the terminal half-life (t ½ ) ranged between 8 to 59 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6da7501b-b881-4bc7-891a-74214a00a3ac (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
Published reports indicate that after multiple dose administration the apparent plasma clearance of methadone ranged between 1.4 and 126 L/h, and the terminal half-life (T 1/2 ) was highly variable and ranged between 8 to 59 hours in different studies.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f0366917-f745-4b01-a662-a98a7d80b4a0 (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
Published reports indicate that after multiple dose administration the apparent plasma clearance of methadone ranged between 1.4 and 126 L/h, and the terminal half-life (T 1/2 ) was highly variable and ranged between 8 to 59 hours in different studies.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:544483e6-6f9d-4371-9e93-313e54e0ea05 (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
Published reports indicate that after multiple dose administration the apparent plasma clearance of methadone ranged between 1.4 and 126 L/h, and the terminal half-life (T 1/2 ) was highly variable and ranged between 8 to 59 hours in different studies.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6984eb5a-57a3-4686-bc67-91bc3e7a531e (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
Published reports indicate that after multiple dose administration the apparent plasma clearance of methadone ranged between 1.4 and 126 L/h, and the terminal half-life (T1/2) was highly variable and ranged between 8 to 59 hours in different studies.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d702d32b-98b1-412d-934c-1cd96af4b95a (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
Published reports indicate that after multiple dose administration the apparent plasma clearance of methadone ranged between 1.4 and 126 L/h, and the terminal half-life (T 1/2 ) was highly variable and ranged between 8 to 59 hours in different studies.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e980d666-d74d-4358-a3b7-c6accb15eba6 (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
Published reports indicate that after multiple dose administration the apparent plasma clearance of methadone ranged between 1.4 and 126 L/h, and the terminal half-life (T 1/2 ) was highly variable and ranged between 8 to 59 hours in different studies.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f935effe-e5b2-4bf7-bbde-6e80bb99076f (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
Published reports indicate that after multiple dose administration the apparent plasma clearance of methadone ranged between 1.4 and 126 L/h, and the terminal half-life (T 1/2 ) was highly variable and ranged between 8 to 59 hours in different studies.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1a536622-dda3-41af-ab08-28e7c1bc9300 (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
Published reports indicate that after multiple dose administration the apparent plasma clearance of methadone ranged between 1.4 and 126 L/h, and the terminal half-life (T 1/2 ) was highly variable and ranged between 8 to 59 hours in different studies.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7a8635fe-6183-4cda-9029-50e4e6dd5832 (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
Published reports indicate that after multiple dose administration the apparent plasma clearance of methadone ranged between 1.4 and 126 L/h, and the terminal half-life (T1/2) was highly variable and ranged between 8 to 59 hours in different studies.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d0e6a966-179a-45e0-8444-4c1b8523f8d2 (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
Published reports indicate that after multiple dose administration the apparent plasma clearance of methadone ranged between 1.4 and 126 L/h, and the terminal half-life (T 1/2 ) was highly variable and ranged between 8 to 59 hours in different studies.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:db52fdc0-765a-4fad-a8f9-ef98c6e4b898 (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
Published reports indicate that after multiple dose administration the apparent plasma clearance of methadone ranged between 1.4 and 126 L/h, and the terminal half-life (T 1/2 ) was highly variable and ranged between 8 to 59 hours in different studies.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:eddf7077-02fb-4771-9823-31984f4ff2bb (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
Published reports indicate that after multiple dose administration the apparent plasma clearance of methadone ranged between 1.4 and 126 L/h, and the terminal half-life (T 1/2 ) was highly variable and ranged between 8 to 59 hours in different studies.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cbc42334-8783-4572-b8da-8c7451d14077 (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
Published reports indicate that after multiple dose administration the apparent plasma clearance of methadone ranged between 1.4 and 126 L/h, and the terminal half-life (T ½ ) was highly variable and ranged between 8 to 59 hours in different studies.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f453f1b9-d46e-4be8-835d-dbeb9d98a149 (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
After single intravenous dose administration the plasma clearance of methadone ranged between 3 L/h to 10 L/h and the terminal half-life (t ½ ) ranged between 8 to 59 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e6af84de-cbfc-4a3b-bd73-6bcf77337168 (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
Published reports indicate that after multiple dose administration the apparent plasma clearance of methadone ranged between 1.4 and 126 L/h, and the terminal half-life (T 1/2 ) was highly variable and ranged between 8 to 59 hours in different studies.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:092d78eb-6423-495c-bf0d-e6532bea7138 (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
After single intravenous dose administration the plasma clearance of methadone ranged between 3 L/h to 10 L/h and the terminal half-life (t ½ ) ranged between 8 to 59 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5baef1bf-8bf0-429c-a4ce-1c93171f3f15 (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
Published reports indicate that after multiple dose administration the apparent plasma clearance of methadone ranged between 1.4 and 126 L/h, and the terminal half-life (T 1/2 ) was highly variable and ranged between 8 to 59 hours in different studies.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7ff89589-149c-4007-8144-5f60131b8c33 (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
Published reports indicate that after multiple dose administration the apparent plasma clearance of methadone ranged between 1.4 and 126 L/h, and the terminal half-life (T 1/2 ) was highly variable and ranged between 8 to 59 hours in different studies.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4a44bde6-c348-4316-b0e0-c24b407cb823 (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
Published reports indicate that after multiple dose administration the apparent plasma clearance of methadone ranged between 1.4 and 126 L/h, and the terminal half-life (T 1/2 ) was highly variable and ranged between 8 to 59 hours in different studies.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8f4cf84e-165c-489d-a668-0f715053f196 (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
Published reports indicate that after multiple dose administration the apparent plasma clearance of methadone ranged between 1.4 and 126 L/h, and the terminal half-life (T 1/2 ) was highly variable and ranged between 8 to 59 hours in different studies.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8c363f90-c378-48ae-abbc-aeb25c9bf5cb (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
Published reports indicate that after multiple dose administration the apparent plasma clearance of methadone ranged between 1.4 and 126 L/h, and the terminal half-life (T 1/2 ) was highly variable and ranged between 8 to 59 hours in different studies.
59 hours
- Numeric value
- 59
- Unit
- hours
- Source records
- 9
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 9 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:714e5adb-bdce-4dff-99aa-4ac3a2f3a0fe (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
Published reports indicate that after multiple dose administration the apparent plasma clearance of methadone ranged between 1.4 and 126 L/h, and the terminal half-life (T 1/2 ) was highly variable and ranged between 8 and 59 hours in different studies.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d5bd3e97-b3f6-4bc2-9fb7-02921be35cdb (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
Published reports indicate that after multiple dose administration the apparent plasma clearance of methadone ranged between 1.4 and 126 L/h, and the terminal half-life (T 1/2 ) was highly variable and ranged between 8 and 59 hours in different studies.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f9dad5d5-3417-4992-99ee-6550f81add6b (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
Published reports indicate that after multiple dose administration the apparent plasma clearance of methadone ranged between 1.4 and 126 L/h, and the terminal half-life (T 1/2 ) was highly variable and ranged between 8 and 59 hours in different studies.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:14f7b1d8-344a-4eaa-a1bf-bc1a00c3ab58 (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
Published reports indicate that after multiple dose administration the apparent plasma clearance of methadone ranged between 1.4 and 126 L/h, and the terminal half-life (T 1/2 ) was highly variable and ranged between 8 and 59 hours in different studies.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e72841bf-364b-49b1-8e69-7e26ddcd2657 (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
Published reports indicate that after multiple dose administration the apparent plasma clearance of methadone ranged between 1.4 and 126 L/h, and the terminal half-life (T 1/2 ) was highly variable and ranged between 8 and 59 hours in different studies.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d7b30c78-c531-4dc5-9552-d68daa3210d1 (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
Published reports indicate that after multiple dose administration the apparent plasma clearance of methadone ranged between 1.4 and 126 L/h, and the terminal half-life (T 1/2 ) was highly variable and ranged between 8 and 59 hours in different studies.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:808a9d0b-720b-4034-a862-5122ff514608 (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
Published reports indicate that after multiple dose administration the apparent plasma clearance of methadone ranged between 1.4 and 126 L/h, and the terminal half-life (T 1/2 ) was highly variable and ranged between 8 and 59 hours in different studies.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0955ea4a-c6b8-431f-ba42-9641b5b102ea (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
Published reports indicate that after multiple dose administration the apparent plasma clearance of methadone ranged between 1.4 and 126 L/h, and the terminal half-life (T 1/2 ) was highly variable and ranged between 8 and 59 hours in different studies.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:373c649e-798d-770e-e063-6294a90a6e47 (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
Published reports indicate that after multiple dose administration the apparent plasma clearance of methadone ranged between 1.4 and 126 L/h, and the terminal half-life (T 1/2 ) was highly variable and ranged between 8 and 59 hours in different studies.
Projected row 958
- Medicine slug
- methadone
- Compared field
- volumeOfDistribution
- Comparison state
- insufficient_context
- Reason codes
- STRUCTURED_CONTEXT_MISSING
- Documents examined
- 36
- Source count
- 36
- Agreement rate
- 0.805556
- Recorded readings
1.0 to 8.0 L/kg
- Numeric value
- 1
- Unit
- L/kg
- Source records
- 29
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 29 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:50f14803-78c0-4d19-8b5d-9a9c17582ac1 (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
Distribution Methadone is a lipophilic drug and the steady-state volume of distribution ranges between 1.0 to 8.0 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:540edd43-165d-4257-b989-3bccc8f54afb (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
Distribution Methadone is a lipophilic drug and the steady-state volume of distribution ranges between 1.0 to 8.0 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4c8b541c-33e8-4969-b258-af150808d46e (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
Distribution Methadone is a lipophilic drug and the steady-state volume of distribution ranges between 1.0 to 8.0 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:714e5adb-bdce-4dff-99aa-4ac3a2f3a0fe (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
Distribution Methadone is a lipophilic drug and the steady-state volume of distribution ranges between 1.0 to 8.0 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6da7501b-b881-4bc7-891a-74214a00a3ac (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
Distribution Methadone is a lipophilic drug and the steady-state volume of distribution ranges between 1.0 to 8.0 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d5bd3e97-b3f6-4bc2-9fb7-02921be35cdb (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
Distribution Methadone is a lipophilic drug and the steady-state volume of distribution ranges between 1.0 to 8.0 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f0366917-f745-4b01-a662-a98a7d80b4a0 (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
Distribution Methadone is a lipophilic drug and the steady-state volume of distribution ranges between 1.0 to 8.0 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f9dad5d5-3417-4992-99ee-6550f81add6b (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
Distribution Methadone is a lipophilic drug and the steady-state volume of distribution ranges between 1.0 to 8.0 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:14f7b1d8-344a-4eaa-a1bf-bc1a00c3ab58 (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
Distribution Methadone is a lipophilic drug and the steady-state volume of distribution ranges between 1.0 to 8.0 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6984eb5a-57a3-4686-bc67-91bc3e7a531e (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
Distribution Methadone is a lipophilic drug and the steady-state volume of distribution ranges between 1.0 to 8.0 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d702d32b-98b1-412d-934c-1cd96af4b95a (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
Distribution Methadone is a lipophilic drug and the steady-state volume of distribution ranges between 1.0 to 8.0 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e980d666-d74d-4358-a3b7-c6accb15eba6 (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
Distribution: Methadone is a lipophilic drug and the steady-state volume of distribution ranges between 1.0 to 8.0 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f935effe-e5b2-4bf7-bbde-6e80bb99076f (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
Distribution : Methadone is a lipophilic drug and the steady-state volume of distribution ranges between 1.0 to 8.0 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1a536622-dda3-41af-ab08-28e7c1bc9300 (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
Distribution Methadone is a lipophilic drug and the steady-state volume of distribution ranges between 1.0 to 8.0 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e72841bf-364b-49b1-8e69-7e26ddcd2657 (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
Distribution Methadone is a lipophilic drug and the steady-state volume of distribution ranges between 1.0 to 8.0 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7a8635fe-6183-4cda-9029-50e4e6dd5832 (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
Distribution: Methadone is a lipophilic drug and the steady-state volume of distribution ranges between 1.0 to 8.0 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d0e6a966-179a-45e0-8444-4c1b8523f8d2 (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
Distribution Methadone is a lipophilic drug and the steady-state volume of distribution ranges between 1.0 to 8.0 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:db52fdc0-765a-4fad-a8f9-ef98c6e4b898 (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
Distribution Methadone is a lipophilic drug and the steady-state volume of distribution ranges between 1.0 to 8.0 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d7b30c78-c531-4dc5-9552-d68daa3210d1 (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
Distribution Methadone is a lipophilic drug and the steady-state volume of distribution ranges between 1.0 to 8.0 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:eddf7077-02fb-4771-9823-31984f4ff2bb (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
Distribution Methadone is a lipophilic drug and the steady-state volume of distribution ranges between 1.0 to 8.0 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cbc42334-8783-4572-b8da-8c7451d14077 (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
Distribution: Methadone is a lipophilic drug and the steady-state volume of distribution ranges between 1.0 to 8.0 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:808a9d0b-720b-4034-a862-5122ff514608 (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
Distribution Methadone is a lipophilic drug and the steady-state volume of distribution ranges between 1.0 to 8.0 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0955ea4a-c6b8-431f-ba42-9641b5b102ea (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
Distribution Methadone is a lipophilic drug and the steady-state volume of distribution ranges between 1.0 to 8.0 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5baef1bf-8bf0-429c-a4ce-1c93171f3f15 (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
Distribution Methadone is a lipophilic drug and the steady-state volume of distribution ranges between 1.0 to 8.0 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7ff89589-149c-4007-8144-5f60131b8c33 (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
Distribution Methadone is a lipophilic drug and the steady-state volume of distribution ranges between 1.0 to 8.0 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4a44bde6-c348-4316-b0e0-c24b407cb823 (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
Distribution Methadone is a lipophilic drug and the steady-state volume of distribution ranges between 1.0 to 8.0 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8f4cf84e-165c-489d-a668-0f715053f196 (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
Distribution Methadone is a lipophilic drug and the steady-state volume of distribution ranges between 1.0 to 8.0 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:373c649e-798d-770e-e063-6294a90a6e47 (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
Distribution Methadone is a lipophilic drug and the steady-state volume of distribution ranges between 1.0 to 8.0 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8c363f90-c378-48ae-abbc-aeb25c9bf5cb (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
Distribution Methadone is a lipophilic drug and the steady-state volume of distribution ranges between 1.0 to 8.0 L/kg.
2 L/kg
- Numeric value
- 2
- Unit
- L/kg
- Source records
- 4
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 4 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:13541167-95f4-4cb9-9d7d-3c1aced5c5f6 (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
Distribution Methadone is a lipophilic drug and the steady state volume of distribution ranges between 2 L/kg to 6 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1a6dbcb0-68f2-4f8b-94ee-baa2aa296293 (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
Distribution Methadone is a lipophilic drug and the steady state volume of distribution ranges between 2 L/kg to 6 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f453f1b9-d46e-4be8-835d-dbeb9d98a149 (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
Distribution Methadone is a lipophilic drug and the steady state volume of distribution ranges between 2 L/kg to 6 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:092d78eb-6423-495c-bf0d-e6532bea7138 (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
Distribution Methadone is a lipophilic drug and the steady state volume of distribution ranges between 2 L/kg to 6 L/kg.
1 to 8 L/kg
- Numeric value
- 1
- Unit
- L/kg
- Source records
- 3
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 3 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c54baaee-8ea4-45f5-a5c8-bb84cf86832f (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
D i stribution: Methadone is a lipophilic drug and the steady-state volume of distribution ranges between 1 to 8 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:544483e6-6f9d-4371-9e93-313e54e0ea05 (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
Distribution Methadone is a lipophilic drug and the steady-state volume of distribution ranges between 1 to 8 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e6af84de-cbfc-4a3b-bd73-6bcf77337168 (opens source in a new tab)
Methadone label
Version not recorded · Effective date not recorded
Distribution: Methadone is a lipophilic drug and the steady-state volume of distribution ranges between 1 to 8 L/kg.
Projected row 959
- Medicine slug
- methamphetamine
- Compared field
- halfLife
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 3
- Source count
- 3
- Agreement rate
- 1
- Recorded readings
4 to 5 hours
- Numeric value
- 4
- Unit
- hours
- Source records
- 3
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 3 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f31f580f-1f08-4a0f-b078-0b9e3308f712 (opens source in a new tab)
Methamphetamine label
Version not recorded · Effective date not recorded
The biological half-life has been reported in the range of 4 to 5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:90c02ac6-e5e2-4c97-8c68-81e4e389a195 (opens source in a new tab)
Methamphetamine label
Version not recorded · Effective date not recorded
The biological half-life has been reported in the range of 4 to 5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d0905e2c-a02f-ec4f-59a3-6f7ad0acbbf6 (opens source in a new tab)
Methamphetamine label
Version not recorded · Effective date not recorded
The biological half-life has been reported in the range of 4 to 5 hours.
Projected row 960
- Medicine slug
- methazolamide
- Compared field
- halfLife
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 12
- Source count
- 12
- Agreement rate
- 1
- Recorded readings
14 hours
- Numeric value
- 14
- Unit
- hours
- Source records
- 12
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 12 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5e0795e1-d5c5-4b04-9bce-077bb8028023 (opens source in a new tab)
Methazolamide label
Version not recorded · Effective date not recorded
The mean steady-state plasma elimination half-life for methazolamide is approximately 14 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:369e89a4-9898-4a9f-a316-17d0fce8a08b (opens source in a new tab)
Methazolamide label
Version not recorded · Effective date not recorded
The mean steady-state plasma elimination half-life for methazolamide is approximately 14 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:042586b3-4d49-c5ae-e063-6394a90aaa7c (opens source in a new tab)
Methazolamide label
Version not recorded · Effective date not recorded
The mean steady-state plasma elimination half-life for methazolamide is approximately 14 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:91a493f5-f8c3-4b64-a15e-b550d8631668 (opens source in a new tab)
Methazolamide label
Version not recorded · Effective date not recorded
The mean steady-state plasma elimination half-life for methazolamide is approximately 14 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1698aa2d-a962-4bcc-8646-4fff532b645b (opens source in a new tab)
Methazolamide label
Version not recorded · Effective date not recorded
The mean steady-state plasma elimination half-life for methazolamide is approximately 14 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c26c8834-961e-4c9c-9ad4-5db2d9419938 (opens source in a new tab)
Methazolamide label
Version not recorded · Effective date not recorded
The mean steady-state plasma elimination half-life for methazolamide is approximately 14 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:504b695a-ac9e-4c71-8755-d31f1958a71c (opens source in a new tab)
Methazolamide label
Version not recorded · Effective date not recorded
The mean steady-state plasma elimination half-life for methazolamide is approximately 14 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:879a3c78-24dd-41f9-8fce-5f3166b0e2f4 (opens source in a new tab)
Methazolamide label
Version not recorded · Effective date not recorded
The mean steady-state plasma elimination half-life for methazolamide is approximately 14 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0c0ba5c7-c53e-4e29-a7ff-48fddc5a9258 (opens source in a new tab)
Methazolamide label
Version not recorded · Effective date not recorded
The mean steady-state plasma elimination half-life for methazolamide is approximately 14 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ff710572-ed62-490a-95f1-2b2c2eed08ee (opens source in a new tab)
Methazolamide label
Version not recorded · Effective date not recorded
The mean steady-state plasma elimination half-life for methazolamide is approximately 14 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1e0e81c7-a328-4034-a6b3-4c83e9ac3a3e (opens source in a new tab)
Methazolamide label
Version not recorded · Effective date not recorded
The mean steady-state plasma elimination half-life for methazolamide is approximately 14 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:723f830c-a534-55d1-e053-2a91aa0a403c (opens source in a new tab)
Methazolamide label
Version not recorded · Effective date not recorded
The mean steady-state plasma elimination half-life for methazolamide is approximately 14 hours.
Access
Query or download the projection
GET /api/datasets/source-consensus?limit=10&offset=950Allowed query parameters
- q
- Case-insensitive text search over the public fields named for this dataset.
- state
- Exact comparability state.Values: agree, differ, not_comparable, insufficient_context
- field
- Exact recorded field key.Values: bioavailability, halfLife, proteinBinding, tMax, volumeOfDistribution
- limit / offset
- Pagination is required. limit is at most 200; offset is bounded. Set format=csv for the same projected page as a download.
Reuse and corrections
Keep the boundary attached
CC BY 4.0 applies to RNAWiki licenses its selection, schema, structure, and derived projection. Quoted source passages and third-party records retain their original rights.
Cite RNAWiki, this dataset identifier, and the generated date. Keep the “does not mean” statement with any downstream display so a corpus measurement is not mistaken for medical advice.